iShares Health Innovation Active ETF (NYSEARCA:BMED) Sees Significant Increase in Short Interest

Posted by Trevor Kearing on Feb 26th, 2026

iShares Health Innovation Active ETF (NYSEARCA:BMED – Get Free Report) was the target of a large increase in short interest in February. As of February 13th, there was short interest totaling 13,489 shares, an increase of 255.1% from the January 29th total of 3,799 shares. Based on an average trading volume of 6,368 shares, the days-to-cover ratio is presently 2.1 days. Currently, 4.2% of the company’s stock are short sold. Currently, 4.2% of the company’s stock are short sold. Based on an average trading volume of 6,368 shares, the days-to-cover ratio is presently 2.1 days.

Hedge Funds Weigh In On iShares Health Innovation Active ETF

A hedge fund recently bought a new stake in iShares Health Innovation Active ETF stock. Sunbelt Securities Inc. acquired a new position in shares of iShares Health Innovation Active ETF (NYSEARCA:BMED – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 11,612 shares of the company’s stock, valued at approximately $352,000. Sunbelt Securities Inc. owned about 3.63% of iShares Health Innovation Active ETF as of its most recent filing with the Securities and Exchange Commission (SEC).

iShares Health Innovation Active ETF Stock Performance

BMED traded down $0.33 during midday trading on Thursday, reaching $30.58. 1,509 shares of the company were exchanged, compared to its average volume of 6,480. The company’s fifty day moving average price is $30.93 and its 200 day moving average price is $28.95. iShares Health Innovation Active ETF has a one year low of $20.57 and a one year high of $32.19. The company has a market cap of $9.78 million, a price-to-earnings ratio of 24.91 and a beta of 0.84.

iShares Health Innovation Active ETF Company Profile

(Get Free Report)

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.